FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program

Building on FACIT and OBIO’s independent successes in backing women entrepreneurs, the Women’s Synergistic Entrepreneurship and Economic Development (WeSEED) program was launched to leverage the combined complementary capital, expertise and resources of each organization. The resulting synergies provide a continuum of seamless support and lower barriers faced by women STEM leaders in accessing business training, advisory resources, networks and venture funding.

Women-led companies in the WeSEED program will have access to and benefit from both FACIT and OBIO’s commercialization resources. OBIO® and FACIT have established track records co-investing and working closely with different commercialization groups locally and globally, increasing value for Ontario life sciences intellectual property and driving economic impact through business tools as well as domestic capital. The WeSEED program and partnership thereby addresses government interests to strengthen the entrepreneurial ecosystem for women-led businesses and impact the local economy.

We are delighted to announce the inaugural WeSEED cohort in partnership with FACIT. This exciting group of women-led companies is poised to transform the oncology landscape, and we look forward to supporting their commercialization journey with our best-in-class programming.
— Dr. Maura Campbell, President of OBIO®
Previous
Previous

OBIO® and TIAP Invest in A4i to Advance AI Analytics for Mental Health Risk Detection

Next
Next

OBIO® Selected by Scale AI to Provide Additional Support to Start-ups